M
MAZE//CIK 0001842295
Maze Therapeutics, Inc.
Market Data
$25.90−$1.43 (−5.23%)
MAZE · Last trade
Prev Close
$27.33
Range (31d)
$25.90 – $30.42
Recent Filings
- 1444.8 KBMaze Therapeutics, Inc.Sep 2, 7:05 PM ET·0001782758-26-000005
- 1447.1 KBMaze Therapeutics, Inc.Sep 2, 7:03 PM ET·0002050167-26-000024
- 14412.0 KBMaze Therapeutics, Inc.Sep 2, 7:02 PM ET·0001676170-26-000019
- 1447.1 KBMaze Therapeutics, Inc.Sep 2, 7:00 PM ET·0002050172-26-000031
- 14411.2 KBMaze Therapeutics, Inc.Sep 1, 4:03 PM ET·0001969223-26-000973
- 8-K175.8 KBMaze Therapeutics, Inc.Aug 17, 4:16 PM ET·0001193125-26-354092
- SCHEDULE 13G/A12.3 KBMaze Therapeutics, Inc.Aug 14, 4:21 PM ET·0001104659-26-097205
- 10-Q10.3 MBMaze Therapeutics, Inc.Aug 11, 4:48 PM ET·0001193125-26-344903
- 8-K328.2 KBMaze Therapeutics, Inc.Aug 11, 4:45 PM ET·0001193125-26-344878
- 14413.2 KBMaze Therapeutics, Inc.Aug 3, 4:08 PM ET·0001969223-26-000823
Insiders
10- Andrews Nancy CDirector
- ARCH Venture Fund X, L.P.10% Owner
- ARCH Venture Partners X, LLC10% Owner
- Bachrodt AmySVP, Finance
- Bernstein HaroldPresident, R&D & CMO
- Brush JamesDirector
- Burow Kristina10% Owner
- Coloma Jason VDirector, Chief Executive Officer
- Colowick AlanDirector
- Courtney PhillipsGC and Corp. Secretary
Tickers
Addresses
business
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080
mailing
171 OYSTER POINT BOULEVARD, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080